Literature DB >> 9035263

Antinociceptive effects of palatable sweet ingesta on human responsivity to pressure pain.

M E Mercer1, M D Holder.   

Abstract

Palatable sweet ingestion produces a morphine-like analgesia in both rats and human infants (2-5). To determine whether palatable sweet ingesta induces antinociception in human adults, 60 university students (30 men, 30 women) were exposed to a pressure algometer both before and after consuming either a sweet soft drink, filtered tap water, or nothing (Experiment 1). Pain responsivity was assessed with four pain measures: threshold, tolerance, and visual analogue scale (VAS) ratings of intensity and unpleasantness. Results showed that women who consumed either soft drink or water reported increased pain tolerance and VAS ratings at posttreatment compared with those receiving nothing. However, differences between groups were not found for men. Moreover, compared to men, women reported lower pain thresholds and tolerances and rated the pain as more intense. In Experiment 2, 40 women consumed either nothing or foods that they rated previously as palatable (chocolate-chip cookies), unpalatable (black olives), or neutral (rice cakes). Women who consumed the palatable sweet food showed increased pain tolerance compared with those receiving the unpalatable food, the neutral food, or nothing. These data constitute the first demonstration that "palatability-induced antinociception" (PIA) can occur in human adults.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9035263     DOI: 10.1016/s0031-9384(96)00400-3

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  19 in total

1.  Effect of the blockade of mu1-opioid and 5HT2A-serotonergic/alpha1-noradrenergic receptors on sweet-substance-induced analgesia.

Authors:  E C C Rebouças; E N Segato; R Kishi; R L Freitas; M Savoldi; S Morato; N C Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2004-12-10       Impact factor: 4.530

2.  Obesity and pain.

Authors:  Donald Scott McVinnie
Journal:  Br J Pain       Date:  2013-11

3.  Greater analgesic effects of sucrose in the neonate predict greater weight gain to age 18 months.

Authors:  Julie C Lumeng; Xing Li; Yunyi He; Ashley Gearhardt; Julie Sturza; Niko A Kaciroti; Ming Li; Katharine Asta; Betsy Lozoff
Journal:  Appetite       Date:  2019-11-04       Impact factor: 3.868

Review 4.  The relationship between opioid and sugar intake: review of evidence and clinical applications.

Authors:  David J Mysels; Maria A Sullivan
Journal:  J Opioid Manag       Date:  2010 Nov-Dec

5.  Smoking status and pain level among head and neck cancer patients.

Authors:  Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

6.  "Do unto others"? Distinct psychopathy facets predict reduced perception and tolerance of pain.

Authors:  Sarah J Brislin; Jennifer M Buchman-Schmitt; Thomas E Joiner; Christopher J Patrick
Journal:  Personal Disord       Date:  2016-03-07

7.  Paradoxical surrogate markers of dental injury-induced pain in the mouse.

Authors:  Jennifer L Gibbs; Rochelle Urban; Allan I Basbaum
Journal:  Pain       Date:  2013-04-11       Impact factor: 6.961

8.  Sucrose consumption enhances the analgesic effects of cigarette smoking in male and female smokers.

Authors:  Robin B Kanarek; Catherine Carrington
Journal:  Psychopharmacology (Berl)       Date:  2004-01-14       Impact factor: 4.530

9.  Analgesia accompanying food consumption requires ingestion of hedonic foods.

Authors:  H Foo; Peggy Mason
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

10.  Fearlessness about death: the psychometric properties and construct validity of the revision to the acquired capability for suicide scale.

Authors:  Jessica D Ribeiro; Tracy K Witte; Kimberly A Van Orden; Edward A Selby; Kathryn H Gordon; Theodore W Bender; Thomas E Joiner
Journal:  Psychol Assess       Date:  2013-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.